Maślan

Źródła naukowe

1. Reddavide R, Rotolo O, Caruso MG, Stasi E, Notarnicola M, Miraglia C, Nouvenne A, Meschi T, De’ Angelis GL, Di Mario F, Leandro G. The role of diet in the prevention and treatment of Inflammatory Bowel Diseases. Acta Biomed. 2018 Dec 17;89(9-S):60-75. doi: 10.23750/abm.v89i9-S.7952. PMID: 30561397; PMCID: PMC6502201.
2. Kallus SJ, Brandt LJ. The intestinal microbiota and obesity. J Clin Gastroenterol. 2012 Jan;46(1):16-24. doi: 10.1097/MCG.0b013e31823711fd. PMID: 22064556.
3. Zhang L., Liu C., Jiang Q., Yin Y., „Butyrate in energy metabolism: There is still more to learn”, Trends Endocrinol Metab, 2021; 323:159–69, doi: 10.1016/j.tem.2020.12.003.
4. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature (2012) 4907418:55–60. doi: 10.1038/nature11450
5. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003 Jul;133(7 Suppl):2485S-2493S. doi: 10.1093/jn/133.7.2485S. PMID: 12840228.
6. Canani R.B., Costanzo M.D., Leone L., Pedata M., Meli R., Calignano A. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology, 17(12):1519-28. DOI: 10.3748/wjg.v17.i12.1519.
7. Vighi G, Marcucci F, Sensi L, Di Cara G, Frati F. Allergy and the gastrointestinal system. Clin Exp Immunol. 2008 Sep;153 Suppl 1(Suppl 1):3-6. doi: 10.1111/j.1365-2249.2008.03713.x. PMID: 18721321; PMCID: PMC2515351.
8. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013 Dec 19;504(7480):451-455. doi: 10.1038/nature12726. PMID: 24226773; PMCID: PMC3869884.
9. Chen J, Vitetta L. The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation. Immune Netw. 2020 Feb 4;20(2):e15. doi: 10.4110/in.2020.20.e15. PMID: 32395367; PMCID: PMC7192831.
10. Bourassa MW, Alim I, Bultman SJ, Ratan RR. Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Neurosci Lett. 2016 Jun 20;625:56-63. doi: 10.1016/j.neulet.2016.02.009. PMID: 26868600; PMCID: PMC4903954.
11. Walsh ME, Shi Y, Van Remmen H. The effects of dietary restriction on oxidative stress in rodents. Free Radic Biol Med. 2014 Nov;66:88-99. doi: 10.1016/j.freeradbiomed.2013.05.037. PMID: 23743291; PMCID: PMC4105179.
12. Zhang J, Rane G, Dai X, et al. Ageing and the telomere connection: An intimate relationship with inflammation. Ageing Res Rev. 2016;25:55-69. doi: 10.1016/j.arr.2015.11.006.
13. Beisner J, Filipe Rosa L, Kaden-Volynets V, Stolzer I, Günther C, Bischoff SC. Prebiotic inulin and sodium butyrate attenuate obesity-induced intestinal barrier dysfunction by induction of antimicrobial peptides. Front Immunol (2021) 12:678360. doi: 10.3389/fimmu.2021.678360
14. den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation. Diabetes (2015) 647:2398–408. doi: 10.2337/db14-1213
15. Li Z, Yi CX, Katiraei S, Kooijman S, Zhou E, Chung CK, et al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut (2018) 677:1269–79. doi: 10.1136/gutjnl-2017-314050
16. Gao F, Lv YW, Long J, Chen JM, He JM, Ruan XZ, et al. Butyrate improves the metabolic disorder and gut microbiome dysbiosis in mice induced by a high-fat diet. Front Pharmacol (2019) 101040:1040. doi: 10.3389/fphar.2019.01040
17. Lin HV, Frassetto A, Kowalik EJ Jr., Nawrocki AR, Lu MM, Kosinski JR, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One (2012) 74:e35240. doi: 10.1371/journal.pone.0035240
18. Canfora EE, van der Beek CM, Jocken JWE, Goossens GH, Holst JJ, Olde Damink SWM, et al. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial. Sci Rep (2017) 71:2360. doi: 10.1038/s41598-017-02546-x
19. Long Nam Nguyen, Livia Cristina Liporagi Lopes, Radames J. B. Cordero, Joshua D. Nosanchuk, Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages, Journal of Antimicrobial Chemotherapy, Volume 66, Issue 11, November 2011, Pages 2573–2580, https://doi.org/10.1093/jac/dkr358
20. Miranda M, Morici JF, Zanoni MB, Bekinschtein P. Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain. Front. Cell. Neurosci. 2019;13:363. doi: 10.3389/fncel.2019.00363
21. Roman M. Stilling, Marcel van de Wouw, Gerard Clarke, Catherine Stanton, Timothy G. Dinan, John F. Cryan,The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?,Neurochemistry International,Volume 99,2016, Pages 110-132, ISSN 0197-0186, https://doi.org/10.1016/j.neuint.2016.06.011.
22. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. 2003 Jul;133(7 Suppl):2485S-2493S. doi: 10.1093/jn/133.7.2485S. PMID: 12840228.
23. Epigenetic Gene Expression and Regulation
24. Chiu CT, Wang Z, Hunsberger JG, Chuang DM. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev. 2013 Jan 8;65(1):105-42. doi: 10.1124/pr.111.005512. PMID: 23300133; PMCID: PMC3565922.
25. Fuchikami M, Yamamoto S, Morinobu S, Okada S, Yamawaki Y, Yamawaki S. The potential use of histone deacetylase inhibitors in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:320-4. doi: 10.1016/j.pnpbp.2015.03.010. Epub 2015 Mar 25. PMID: 25818247.
26. Cheung SG, Goldenthal AR, Uhlemann AC, Mann JJ, Miller JM, Sublette ME. Systematic Review of Gut Microbiota and Major Depression. Front Psychiatry. 2019 Feb 11;10:34. doi: 10.3389/fpsyt.2019.00034. PMID: 30804820; PMCID: PMC6378305.
27. Jiaming Liu, Jing Sun, Fangyan Wang, Xichong Yu, Zongxin Ling, Haixiao Li, Huiqing Zhang, Jiangtao Jin, Wenqian Chen, Mengqi Pang, Junjie Yu, Yiwen He, Jiru Xu, „Neuroprotective Effects of Clostridium butyricum against Vascular Dementia in Mice via Metabolic Butyrate”, BioMed Research International, vol. 2015, Article ID 412946, 12 pages, 2015. https://doi.org/10.1155/2015/412946
28. Rios-Covian D, Gueimonde M, Duncan SH, Flint HJ, de los Reyes-Gavilan CG. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett. 2015 Nov;362(21):fnv176. doi: 10.1093/femsle/fnv176. Epub 2015 Sep 28. PMID: 26420851.
29. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol (1996) 813:288–302. doi: 10.1111/j.1365-2672.1996.tb04331.x
30. Smith EA, Macfarlane GT. Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe (1997) 35:327–37. doi: 10.1006/anae.1997.0121
31. Iriki T, Tamura K, Ishii M, Tanaka H, Miyamoto T, Onda K. Concentrations of ketone body and antidiuretic hormone in cerebrospinal fluid in response to the intra-ruminal administration of butyrate in suckling calves. Anim Sci J. 2009 Dec;80(6):655-61. doi: 10.1111/j.1740-0929.2009.00683.x. PMID: 20163655.
32. Aitoro R, Paparo L, Amoroso A, Di Costanzo M, Cosenza L, Granata V, et al. Gut microbiota as a target for preventive and therapeutic intervention against food allergy. Nutrients (2017) 9(7):672. doi: 10.3390/nu9070672
33. Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 2007;61:37–41. https://doi.org/10.1203/01.pdr.0000250014.92242.f3
34. P. Kundu et al., Neurogenesis and Prolongevity Signaling in Young Germ-Free Mice Transplanted With the Gut Microbiota of Old Mice, Sci Transl Med, 2019, nr 11(518).
35. Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochem Int. 2016 Oct;99:110–132. doi: 10.1016/j.neuint.2016.06.011
36. Tirandaz H, Mohammadi E. Efficient tumor targeting by anaerobic butyrate-producing bacteria. Med Hypotheses. 2013 May;80(5):675-8. doi: 10.1016/j.mehy.2013.01.024. Epub 2013 Feb 12. PMID: 23410499.
37. Singh NP, Lai HC. Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res. 2005 Nov-Dec;25(6B):4325-31. PMID: 16309236.